Dr. Sachida Manocha, M.D

NPI: 1821036435
Total Payments
$13,773
2024 Payments
$1,159
Companies
52
Transactions
759
Medicare Patients
3,575
Medicare Billing
$522,952

Payment Breakdown by Category

Food & Beverage$12,419 (90.2%)
Other$1,141 (8.3%)
Travel$210.72 (1.5%)
Education$2.56 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $12,419 755 90.2%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,141 1 8.3%
Travel and Lodging $210.72 2 1.5%
Education $2.56 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Abbott Laboratories $1,592 17 $0 (2022)
Medtronic, Inc. $1,493 26 $0 (2024)
ABBVIE INC. $1,382 104 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,211 95 $0 (2024)
Medtronic USA, Inc. $1,077 26 $0 (2020)
Supernus Pharmaceuticals, Inc. $1,012 101 $0 (2022)
Collegium Pharmaceutical, Inc. $857.04 71 $0 (2024)
Nevro Corp. $458.82 22 $0 (2024)
Purdue Pharma L.P. $432.35 39 $0 (2018)
Biohaven Pharmaceuticals, Inc. $351.77 25 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,159 55 Medtronic, Inc. ($319.55)
2023 $1,360 73 ABBVIE INC. ($300.89)
2022 $2,414 130 ABBVIE INC. ($397.66)
2021 $2,412 154 Medtronic, Inc. ($536.90)
2020 $754.80 47 Supernus Pharmaceuticals, Inc. ($145.33)
2019 $1,190 65 Medtronic USA, Inc. ($242.42)
2018 $2,436 83 Abbott Laboratories ($1,141)
2017 $2,046 152 Purdue Pharma L.P. ($394.02)

All Payment Transactions

759 individual payment records from CMS Open Payments — Page 1 of 31

Date Company Product Nature Form Amount Type
12/11/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $20.65 General
Category: Opioid Analgesic
11/13/2024 Forte Bio-Pharma LLC NALOCET (Drug), PROLATE, PROLATE Food and Beverage In-kind items and services $14.20 General
Category: PAIN
11/12/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $16.99 General
Category: Gastroenterology
11/12/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $1.50 General
Category: Gastroenterology
11/06/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $19.02 General
Category: Opioid Analgesic
10/31/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $20.08 General
Category: Gastroenterology
10/08/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $15.13 General
Category: Opioid Analgesic
09/24/2024 Forte Bio-Pharma LLC PROLATE (Drug), NALOCET, PROLATE Food and Beverage In-kind items and services $14.85 General
Category: PAIN
09/19/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $23.98 General
Category: NEUROSCIENCE
09/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $14.42 General
Category: Gastroenterology
09/17/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $13.89 General
Category: PAIN
08/28/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $15.44 General
Category: Gastroenterology
08/21/2024 Medtronic, Inc. SYNCHROMEDII (Device) Food and Beverage In-kind items and services $80.27 General
Category: Drug Infusion Systems
08/14/2024 Forte Bio-Pharma LLC NALOCET (Drug), PROLATE, PROLATE Food and Beverage In-kind items and services $16.83 General
Category: PAIN
08/14/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $8.25 General
Category: NEUROSCIENCE
08/13/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $23.96 General
Category: NEUROSCIENCE
08/13/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $3.94 General
Category: NEUROSCIENCE
08/07/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $12.22 General
Category: Gastroenterology
07/30/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $24.64 General
Category: Opioid Analgesic
07/30/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $7.04 General
Category: Gastroenterology
07/25/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $14.02 General
Category: NEUROSCIENCE
07/02/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $14.60 General
Category: Opioid Analgesic
06/26/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $12.78 General
Category: NEUROSCIENCE
06/26/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $3.51 General
Category: Gastroenterology
06/12/2024 Forte Bio-Pharma LLC NALOCET (Drug), PROLATE, PROLATE Food and Beverage In-kind items and services $16.44 General
Category: PAIN

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 22 669 3,137 $507,777 $96,700
2022 21 796 2,931 $508,485 $110,515
2021 29 1,044 4,142 $753,437 $183,713
2020 25 1,066 3,889 $672,239 $132,024
Total Patients
3,575
Total Services
14,099
Medicare Billing
$522,952
Procedure Codes
97

All Medicare Procedures & Services

97 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 119 501 $94,035 $30,197 32.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 83 165 $36,300 $13,763 37.9%
62370 Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician Office 2023 37 138 $97,980 $7,882 8.0%
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg Office 2023 11 648 $22,680 $6,598 29.1%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 40 40 $14,990 $6,315 42.1%
62323 Injection of substance into lower spine canal using imaging guidance Office 2023 25 33 $21,615 $6,094 28.2%
76942 Ultrasonic guidance for needle placement Office 2023 45 152 $50,160 $5,368 10.7%
27096 Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance Office 2023 15 24 $28,800 $3,471 12.1%
62350 Insertion, revision, or repositioning of spinal canal tube for medication administration Facility 2023 13 13 $23,400 $3,179 13.6%
77002 Fluoroscopic guidance for needle placement Office 2023 20 35 $5,600 $2,781 49.7%
62368 Electronic analysis and reprogramming of spinal canal drug infusion pump Office 2023 25 90 $18,000 $2,598 14.4%
64493 Injection of lower or sacral spine facet joint using imaging guidance, single level Office 2023 12 16 $15,270 $2,162 14.2%
62362 Insertion of programmable spinal canal drug infusion pump Facility 2023 14 14 $51,800 $1,846 3.6%
20610 Aspiration and/or injection of fluid from large joint Office 2023 12 24 $6,600 $1,326 20.1%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 22 26 $3,102 $1,065 34.3%
J1040 Injection, methylprednisolone acetate, 80 mg Office 2023 41 96 $2,400 $858.07 35.8%
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional Office 2023 26 27 $2,025 $463.86 22.9%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2023 26 339 $3,390 $284.92 8.4%
61070 Aspiration of cerebrospinal fluid and injection in shunt tubing or reservoir Facility 2023 14 14 $2,100 $246.05 11.7%
J1030 Injection, methylprednisolone acetate, 40 mg Office 2023 11 22 $330.00 $133.62 40.5%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2023 19 505 $5,050 $44.73 0.9%
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Office 2023 39 215 $2,150 $24.29 1.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 122 611 $106,925 $38,087 35.6%
62323 Injection of substance into lower spine canal using imaging guidance Office 2022 39 62 $40,610 $11,737 28.9%
62370 Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician Office 2022 39 166 $117,860 $10,493 8.9%

About Dr. Sachida Manocha, M.D

Dr. Sachida Manocha, M.D is a Pain Medicine healthcare provider based in Newark, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821036435.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sachida Manocha, M.D has received a total of $13,773 in payments from pharmaceutical and medical device companies, with $1,159 received in 2024. These payments were reported across 759 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($12,419).

As a Medicare-enrolled provider, Manocha has provided services to 3,575 Medicare beneficiaries, totaling 14,099 services with total Medicare billing of $522,952. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.

Practice Information

  • Specialty Pain Medicine
  • Other Specialties Interventional Pain Medicine
  • Location Newark, OH
  • Active Since 06/04/2006
  • Last Updated 08/21/2023
  • Taxonomy Code 207LP2900X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1821036435

Products in Payments

  • RELISTOR (Drug) $1,237
  • TROKENDI XR (Drug) $975.76
  • UBRELVY (Drug) $833.75
  • XTAMPZA (Drug) $733.23
  • NURTEC ODT (Drug) $671.71
  • ADAPTIVESTIM (Device) $618.45
  • SYNCHROMED (Device) $589.63
  • QULIPTA (Drug) $561.56
  • SYNCHROMEDII (Device) $483.41
  • INTELLIS ADAPTIVESTIM (Device) $472.74
  • INTELLIS (Device) $263.88
  • Qutenza (Drug) $248.00
  • Senza Spinal Cord Stimulation System (Device) $247.20
  • Horizant (Drug) $225.22
  • Proclaim Family of SCS IPGs (Device) $205.15
  • BELBUCA (Drug) $199.88
  • ARYMO ER (Drug) $182.11
  • Aimovig (Biological) $160.29
  • Evzio (Drug) $157.14
  • mild Device Kit (Device) $147.19

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pain Medicine Doctors in Newark